Progress and prospects: RNA-based therapies for treatment of HIV infection.
about
T cell-specific siRNA delivery suppresses HIV-1 infection in humanized miceDigoxin suppresses HIV-1 replication by altering viral RNA processingTrafficking through the Rev/RRE pathway is essential for efficient inhibition of human immunodeficiency virus type 1 by an antisense RNA derived from the envelope gene.Analysis of siRNA specificity on targets with double-nucleotide mismatchesThe efficacy of generating three independent anti-HIV-1 siRNAs from a single U6 RNA Pol III-expressed long hairpin RNA.Effective treatment of respiratory alphaherpesvirus infection using RNA interference.High-throughput screening of effective siRNAs using luciferase-linked chimeric mRNAComputational models of HIV-1 resistance to gene therapy elucidate therapy design principlesAptamer-targeted cell-specific RNA interferenceHIV sequence variation associated with env antisense adoptive T-cell therapy in the hNSG mouse modelA re-examination of global suppression of RNA interference by HIV-1.Cell-type-specific aptamer and aptamer-small interfering RNA conjugates for targeted human immunodeficiency virus type 1 therapy.Co-delivery of docetaxel and endostatin by a biodegradable nanoparticle for the synergistic treatment of cervical cancer.Protection of HIV neutralizing aptamers against rectal and vaginal nucleases: implications for RNA-based therapeutics.Self-assembling RNA nanorings based on RNAI/II inverse kissing complexes.Surface modification of TPGS-b-(PCL-ran-PGA) nanoparticles with polyethyleneimine as a co-delivery system of TRAIL and endostatin for cervical cancer gene therapy.Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibitionAn aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4(+) T cell decline in humanized mice.Cell-specific RNA aptamer against human CCR5 specifically targets HIV-1 susceptible cells and inhibits HIV-1 infectivity.Systemic administration of combinatorial dsiRNAs via nanoparticles efficiently suppresses HIV-1 infection in humanized miceFunctional in vivo delivery of multiplexed anti-HIV-1 siRNAs via a chemically synthesized aptamer with a sticky bridgeTherapeutic potential of aptamer-siRNA conjugates for treatment of HIV-1.Methods for assessing DNA hybridization of peptide nucleic acid-titanium dioxide nanoconjugatesAptamer-based therapeutics: new approaches to combat human viral diseasesSilencing sexually transmitted infections: topical siRNA-based interventions for the prevention of HIV and HSVRNA interference-based therapeutics for human immunodeficiency virus HIV-1 treatment: synthetic siRNA or vector-based shRNA?Current progress in the development of RNAi-based therapeutics for HIV-1RNA-based gene therapy for the treatment and prevention of HIV: from bench to bedside.Recent progress in biomedical applications of titanium dioxide.Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors.
P2860
Q24603574-DD09BA10-06DD-41BF-A163-1B31A0D38FBDQ28489086-5C93A6D4-616F-4A16-BEE1-3C6E8DBB0066Q30439325-F2D62AD0-32E2-4DB4-80BF-0C06377E087CQ33329034-7E7CF3B1-AC5C-46C9-A7B3-8794653B7243Q33348656-C63E3BE6-71EC-4504-8DB8-25E855CDA4FBQ33397374-97E89A1D-D466-45F3-AE41-43FB3D8EF5EDQ33617892-D70BA56F-2220-4644-A6BF-B80A8DA89600Q33658642-2D675D53-02E0-4AB7-A587-4D8CDA89C763Q33717239-5C18B5D1-2EF1-4EB7-A75A-22633B0FBCC2Q33822232-21B23697-A69B-43FC-9775-64991672558CQ33840754-C6BFB131-668F-44E6-AE98-596277065DEFQ34232003-267C9B84-9701-4899-ACEF-EB00D9AF340CQ34502283-BF14D467-49C7-4846-BC48-B1101B923EF8Q34509294-5D69C078-2A47-4B79-8BCA-791AEDF4710FQ34564940-EBCBFA0A-C1F8-45E6-B48B-24A19C57F9F0Q34660767-836189E8-FD05-44C0-8031-9B65B7184CCFQ35024012-38B8ED27-74CB-40DA-ADE6-1ABC2B2FE2C3Q35111705-B848CFDD-2CC5-43F4-938F-B02D8F2AEEC6Q35205365-7BACE3FD-E6AD-4CC3-AC81-5AA23832BA43Q35623481-36EA02A3-48CA-433C-AAF3-88BC44034B33Q36512567-00B01615-7E6D-4010-BACD-811EDB68742BQ36839458-3479C2CB-DDFF-40EC-BC07-25BC7CA26CD6Q37002195-47B428CE-CC16-4396-BB8B-9B592F4D698FQ37415958-A600FA8E-D4A8-4C69-9262-7612298B149FQ37553822-5A3B1AD2-792E-48E9-9FF5-C1490427DFF9Q37678411-D2E9FC2D-9DFB-4BEA-9D17-4B008105FFD9Q37940340-BB750366-0066-4C20-B0CD-C5A9945CBC99Q37941651-C26E0E63-6A4F-4D2A-8BD6-D0122F1AB39EQ38085573-E07B95EC-8CC6-4FF7-88F9-E0B588BEBFFCQ38212101-8910A326-E8BB-4065-A961-177E5EB0A4A5
P2860
Progress and prospects: RNA-based therapies for treatment of HIV infection.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Progress and prospects: RNA-based therapies for treatment of HIV infection.
@en
type
label
Progress and prospects: RNA-based therapies for treatment of HIV infection.
@en
prefLabel
Progress and prospects: RNA-based therapies for treatment of HIV infection.
@en
P2860
P356
P1433
P1476
Progress and prospects: RNA-based therapies for treatment of HIV infection
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.GT.3302977
P577
2007-07-01T00:00:00Z